This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Mouse Anti-Chicken ATP-Citrate Synthase (ACLY) Monoclonal Antibody
Product Overview
BioVenic mouse monoclonal antibody is specific for chicken ATP-citrate synthase. It can be applied to WB, IF, ICC and FCM assays of chicken ATP-citrate synthase.
Specifications
Target Information
ATP-citrate synthase (ACLY) is a key regulatory enzyme involved in the conversion of citrate to cytosolic acetyl-CoA, a reaction that is essential for fatty acid synthesis and cholesterol production. This enzyme catalyzes the ATP-dependent cleavage of citrate to yield acetyl-CoA and oxaloacetate, with the acetyl-CoA serving as a building block for fatty acid synthesis and cholesterol while the oxaloacetate can enter the tricarboxylic acid (TCA) cycle. ACLY is a critical node in metabolic pathways, integrating signals from various cellular processes, including nutrient availability and energy status. Its activity is tightly regulated at multiple levels, including transcriptional, post-translational, and allosteric mechanisms, to balance the cellular demand for lipid production and energy metabolism.
Shipping and Storage
This product is shipped with ice gel packs. Store at -20°C (up to 12 months) on receipt. Avoid repeated freezing and thawing as this may denature the antibody.
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.
References
- Wei, Xuepeng, et al. "Allosteric role of the citrate synthase homology domain of ATP citrate lyase." Nature Communications 14.1 (2023): 2247.